SA
LinkedIn

Sebastian A. Brunemeier

LongBio VC | Drug Hunter-Gatherer

Lisbon, Lisbon, Portugal · 1 connection

Healthspan Capital

Not on Unlinked · Imported profile. Is this you? Claim it

About

Building and investing in longevity biotech ("LongBio") companies that address the molecular mechanisms of aging ("geroscience"). - GP @ Healthspan Capital - Co-founder & CIO of Cambrian Bio - Principal at Apollo Health Ventures - Founder & COO of Samsara Therapeutics - CEO @ ImmuneAGE Bio, Cyclone Tx - Oxford Biochemistry PhD (DPhil) dropout (to co-found Cambrian) and Clarendon Scholar - MSc in Molecular Neuro & Biotech Business Management @ Uni Amsterdam - Advisor to Longevity Biotech Fellowship, LongGame Ventures, and more Bio: Sebastian A. Brunemeier is a biotech VC and company builder focused on longevity & regenerative medicine. He is Co-Founder and General Partner of Healthspan Capital, and CEO and Founder of ImmuneAGE Bio (stealth), focused on immune system rejuvenation. Over the last 5 years, he has co-founded 4 longevity biotech (“LongBio”) companies with a total equity value of >$600M. He was Co-Founder and Chief Investment Officer at Cambrian Biopharma, Founder and COO of Samsara Therapeutics, and Principal at Apollo Health Ventures (the first and largest aging-focused venture capital fund in the world with $200M AUM). Altogether, these organizations have raised ±$400M

Experience

Co-founder & PartnerHealthspan Capital
Aug 2021
Venture PartnerLongGame Ventures
Nov 2024
Faculty LecturerGeneva College of Longevity Science
May 2024
FounderLongBio Institute
Aug 2024
Longevity Working GroupVitaDAO
Sep 2020
Initiator & Committee MemberLongevity Prize
Jun 2022
Advisory BoardAlpine Institute
Jan 2022
AdvisorMolecule
Sep 2020
Board MemberRevivo Therapeutics
Nov 2020
Advisory Board & InvestorEquator Therapeutics
Dec 2020
AdvisorSamsara Therapeutics
Jan 2020
Founder & COOSamsara Therapeutics
Jan 2018 to Jan 2020
Venture ScoutPicus Capital
Dec 2021
CEO & FounderImmuneAGE Bio
Jan 2022 to Sep 2025
ODLB -- Advisor & Founding Fellow - Longevity Biotech Fellowshipodf
Jul 2021 to Apr 2023
AdvisorMcKinsey & Company
Oct 2019 to Jan 2021
CIO & Co-FounderCambrian Bio
Sep 2019 to Sep 2020
CEO & Co-FounderCyclone Therapeutics
Jan 2019 to Jan 2020
PrincipalApollo Health Ventures
Jan 2018 to Dec 2019
AssociateDeep Knowledge Group
Jul 2016 to Dec 2017
Fulbright Research FellowU.S. Department of State
Sep 2014 to Aug 2015
Lab ManagerPascal Chemistry
Feb 2014 to Sep 2014
Research AssistantCaltech
Sep 2013 to Feb 2014
SENS Research Foundation ScholarBuck Institute for Research on Aging
Jun 2012 to Sep 2012

Education

University of Oxford
PhD (DPhil) studies (ABD), Biochemistry of aging. Clarendon Scholarship
Scripps Research
Skaggs-Oxford Scholar Fellowship (joint PhD program with Oxford, awarded but paused), Dept of Molecular Medicine
University of Amsterdam
MSc, Biomedical Science (Molecular Neuroscience)
Vrije Universiteit Amsterdam (VU Amsterdam)
Masters of Business Management (joint MSc w UvA), Life Science Business Management
Pitzer College
Bachelor's, Human Biology (Honors)
University of Lisbon
Fulbright Fellowship, Telomere biology & cellular senescence
Icahn School of Medicine at Mount Sinai
Honors Undergrad Thesis